Live Breaking News & Updates on Semin ophthalmol

Stay informed with the latest breaking news from Semin ophthalmol on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Semin ophthalmol and stay connected to the pulse of your community

Age-related macular degeneration

Age-related macular degeneration is an increasingly important public health issue
due to ageing populations and increased longevity. Age-related macular degeneration
affects individuals older than 55 years and threatens high-acuity central vision required
for important tasks such as reading, driving, and recognising faces. Advances in retinal
imaging have identified biomarkers of progression to late age-related macular degeneration.
New treatments for neovascular age-related macular degeneration offer potentially
longer-lasting effects, and progress is being made towards a treatment for atrophic
late age-related macular degeneration.

Wisconsin , United-states , London , City-of , United-kingdom , Australia , Philadelphia , Pennsylvania , Israel , South-korea , Scotland , Han